Showing results (131-140 of 259) with videos related to
Sort By:
Pageof 26
British Journal of Cancer|January 1, 1996
Cisplatin and taxol activate different signal pathways regulating cellular injury-induced expression of GADD153D P Gately, A Sharma, R D Christen, et al.Cancer Treatment Reports|June 1, 1986
Ip chemotherapy employing a regimen of cisplatin, cytarabine, and bleomycinM Markman, S Cleary, W Lucas, et al.Cancer Research|January 1, 1988
cis-Diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cellsP A Andrews, S Velury, S C Mann, et al.Cancer Research|August 1, 1987
Multivesicular liposomes containing 1-beta-D-arabinofuranosylcytosine for slow-release intrathecal therapyS Kim, D J Kim, M A Geyer, et al.Cancer Research|March 1, 1983
Intraperitoneal cis-diamminedichloroplatinum with systemic thiosulfate protectionS B Howell, C E Pfeifle, W E Wung, et al.The Laryngoscope|January 1, 1996
"Decadose" effects of cisplatin on squamous cell carcinoma of the upper aerodigestive tract. II. Clinical studiesK T Robbins, A M Storniolo, W M Hryniuk, et al.Cancer Communications|January 1, 1990
Rapid emergence of acquired cis-diamminedichloroplatinum(II) resistance in an in vivo model of human ovarian carcinomaP A Andrews, J A Jones, N M Varki, et al.Chemico-Biological Interactions|January 1, 1988
Enhanced potentiation of cisplatin cytotoxicity in human ovarian carcinoma cells by prolonged glutathione depletionP A Andrews, M A Schiefer, M P Murphy, et al.Molecular Biology & Medicine|June 1, 1987
Gene therapy for thioguanine-resistant human leukemiaS B Howell, M P Murphy, J Johnson, et al.Cancer|October 15, 1982
Comparison of the activity of doxorubicin analogues using colony-forming assays and human xenograftsR Taetle, S B Howell, F C Giuliani, et al.Pageof 26